Analysed REPLIGEN CORP (RGEN:NASDAQ) News Sources
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.
25-08-2026
247wallst.com
Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks
17-08-2026
yahoo.com
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
26-08-2026
yahoo.com
What is the current price of REPLIGEN CORP (RGEN:NASDAQ)?
The current price of REPLIGEN CORP (RGEN:NASDAQ) is $182.03.
REPLIGEN CORP (RGEN:NASDAQ) absolute price change since previous trading day?
The absolute price change of REPLIGEN CORP (RGEN:NASDAQ) since the previous trading day is $1.73.
REPLIGEN CORP (RGEN:NASDAQ) percentage price change since previous trading day?
The percentage price change of REPLIGEN CORP (RGEN:NASDAQ) since the previous trading day is 0.9595%.
What is the most recent average sentiment score for REPLIGEN CORP (RGEN:NASDAQ)?
The most recent average sentiment score for REPLIGEN CORP (RGEN:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for REPLIGEN CORP (RGEN:NASDAQ)?
The most recent sentiment for REPLIGEN CORP (RGEN:NASDAQ) is .
SEC-8K** Filing Available For REPLIGEN CORP (RGEN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.